| Men (n = 359) | Women (n = 412) | ||||
---|---|---|---|---|---|---|
 | Metabolic syndrome | Metabolic syndrome | ||||
Baseline characteristics | Yes (n = 163) | No (n = 196) | P value | Yes (n = 96) | No (n = 316) | P value |
Age (years)* | 61.86 (±0.83) | 60.32 (±0.77) | 0.17 | 64.96 (±0.88) | 58.52 (±0.55) | <0.001 |
Sitting Systolic BP (mmHg)* | 141.34 (±1.27) | 132.26 (±1.15) | <0.001 | 151.82 (±1.16) | 137.49 (±0.96) | <0.001 |
Sitting Diastolic BP (mmHg)* | 85.69 (±0.77) | 80.79 (±0.73) | <0.001 | 89.27 (±0.92) | 82.67 (±0.51) | <0.001 |
Antihypertensive Therapy (%) | 50.9% | 28.4% | <0.001 | 60.4% | 29.4% | <0.001 |
Total Cholesterol (mmol/L)* | 5.61 (±0.08) | 5.70 (±0.08) | 0.56 | 6.04 (±0.1) | 5.99 (±0.06) | 0.67 |
LDL cholesterol (mmol/L)* | 3.44 (±0.06) | 3.49 (±0.06) | 0.52 | 3.58 (± 0.06) | 3.54 (± 0.04) | 0.66 |
HDL cholesterol (mmol/L)* | 1.03 (±0.63) | 1.27 (±0.02) | <0.001 | 1.20 (± 0.02) | 1.48 (±0.016) | <0.001 |
Triglycerides (mmol/L)†| 2.10 (1.63; 2.64) | 1.32 (0.98; 1.57) | <0.001 | 2.15 (1.78; 2.83) | 1.24 (0.97; 1.56) | <0.001 |
Diabetes mellitus (%) | 30.7% | 6.3% | <0.001 | 33.3% | 2.3% | <0.001 |
BMI (kg/m 2 )* | 29.88 (±0.35) | 26.06 (±0.2) | <0.001 | 32.39 (±0.47) | 26.95 (±0.25) | <0.001 |
ApoA1 (g/L)* | 1.29 (±0.013) | 1.40 (±0.017) | <0.001 | 1.44 (±0.02) | 1.55 (±0.001) | <0.001 |
ApoB (g/L)* | 1.21 (±0.02) | 1.19 (±0.02) | 0.48 | 1.23 (±0.02) | 1.18 (±0.014) | 0.044 |
Homa index†| 2.25(1.15; 4.18) | 0.94(0.51; 1.8) | <0.001 | 2.51 (1.67; 3.86) | 1.14 (0.72; 1.7) | <0.001 |
IMTccMean (mm)* | 0.79 (±0.15) | 0.76 (±0.12) | 0.084 | 0.77 (±0.16) | 0.69 (±0.13) | <0.001 |
Sum of total plaque area (mm 2 )†| 53 (25; 103) | 42 (10;72) | 0.002 | 16 (1; 44) | 8 (1;32) | 0.01 |
Sum of plaque area carotids (mm 2 )†| 22 (1; 39) | 12 (1; 27.5) | 0.011 | 8.75 (1;25.75) | 1 (1; 19) | 0.013 |
Sum of plaque area femoral (mm 2 )†| 33(10; 62) | 23(1; 49) | 0.011 | 1(1; 17.75) | 1(1; 6) | 0.012 |